Exuberant Endothelial C5b-9 Formation in Recurrent and De Novo Posttransplant Thrombotic MicroangiopathyKIDNEY INTERNATIONAL REPORTSIF5.72024-11-010OAAI
An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndromeFRONTIERS IN IMMUNOLOGYIF5.92023-02-096OAAI
SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet AggregationFRONTIERS IN IMMUNOLOGYIF5.92022-03-0748OAAI
C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19BLOOD ADVANCESIF7.12022-02-0140OAAI
Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration PlasmapheresisFRONTIERS IN IMMUNOLOGYIF5.92021-06-301OAAI
Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 VariantFRONTIERS IN MEDICINEIF32020-11-039OAAI
An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic SyndromeAMERICAN JOURNAL OF KIDNEY DISEASESIF8.22019-07-0175PREAI
Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathiesTHROMBOSIS AND HAEMOSTASISIF4.32017-12-1490PREAI
In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTSI3 in thrombotic thrombocytopenic purpuraTHROMBOSIS AND HAEMOSTASISIF4.32017-11-2967PREAI
Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodiesTHROMBOSIS AND HAEMOSTASISIF4.32017-11-2377PREAI
Interaction between multimeric VWF and complement: A fresh look to the pathophysiology of microvascular thrombosisMOLECULAR IMMUNOLOGYIF32017-09-010PREAI
Treatment of Congenital Thrombotic Thrombocytopenic Purpura With EculizumabAMERICAN JOURNAL OF KIDNEY DISEASESIF8.22015-12-0120PREAI
ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal ImpairmentCLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGYIF7.12015-11-0114OA
Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related DiseaseEBIOMEDICINEIF10.82015-05-0126OAAI
A Novel Antibody against Human Factor B that Blocks Formation of the C3bB Proconvertase and Inhibits Complement Activation in Disease ModelsJOURNAL OF IMMUNOLOGYIF3.42014-12-0115PREAI
ADAMTS13 Predicts Renal and Cardiovascular Events in Type 2 Diabetic Patients and Response to TherapyDIABETESIF7.52013-09-1729OAAI
Two Patients With History of STEC-HUS, Posttransplant Recurrence and Complement Gene MutationsAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22013-08-0140OA
In patients with atypical hemolytic uremic syndrome C5 activation causes loss of endothelial thromboresistanceMOLECULAR IMMUNOLOGYIF32011-08-011PREAI
Membranous Nephropathy Associated With IgG4-Related Disease与IgG4-Related疾病相关的膜性肾病AMERICAN JOURNAL OF KIDNEY DISEASESIF8.22011-08-0163PRE